Mealey's (September 29, 2022, 2:48 PM EDT) -- WASHINGTON, D.C. — In a miscellaneous order issued Sept. 29, the U.S. Supreme Court halted plans by various drugmakers to launch a generic version of the multiple sclerosis drug Gilenya, in a win for patent owner Novartis Pharmaceuticals Corp....